Education
About Us
Working with TipRanks
Follow Us
Reckitt Benckiser Group Plc (RBGLY)
OTHER OTC:RBGLY
Top Page
Reckitt Benckiser Group
(OTC:RBGLY)
Select Model
Select Model
Rating:78Outperform
Price Target:
$17.00
▲(8.14% Upside)
Reckitt Benckiser Group's overall stock score is driven by strong financial performance and positive technical indicators. The optimistic earnings call further supports the score, despite high valuation concerns. Challenges in specific markets and product lines are noted but are outweighed by the company's robust growth in emerging markets and cost-saving initiatives.
Reckitt Benckiser Group (RBGLY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$53.54B
Dividend Yield3.34%
Average Volume (3M)20.41K
Price to Earnings (P/E)34.0
Beta (1Y)0.07
Revenue Growth0.29%
EPS Growth-14.19%
CountryUS
Employees37,900
SectorN/A
Sector StrengthN/A
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)0.38
Shares Outstanding3,362,570,000
10 Day Avg. Volume51,522
30 Day Avg. Volume20,409
Financial Highlights & Ratios
PEG Ratio-2.16
Price to Book (P/B)5.02
Price to Sales (P/S)2.37
P/FCF Ratio15.17
Enterprise Value/Market Cap1.08
Enterprise Value/Revenue4.15
Enterprise Value/Gross Profit6.81
Enterprise Value/Ebitda20.89
Forecast
1Y Price Target
$15.05Price Target Upside-4.26% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.94
Revenue Forecast (FY)$18.96B
Reckitt Benckiser Group Business Overview & Revenue Model
Company DescriptionReckitt Benckiser Group (RBGLY) is a global consumer goods company based in the UK, specializing in health, hygiene, and home products. Established in 1823, the company operates across several key sectors, including health, hygiene, and nutrition. Its core product lines include well-known brands such as Dettol, Lysol, Air Wick, Durex, and Nurofen, which cater to everyday consumer needs across the globe.
How the Company Makes MoneyReckitt Benckiser generates revenue primarily through the sale of its branded consumer products in health, hygiene, and nutrition sectors. The company employs a multi-channel distribution strategy, selling products through retailers, e-commerce platforms, and direct-to-consumer channels. Key revenue streams include over-the-counter health products, household cleaning agents, and personal care items. Additionally, RBGLY benefits from strong brand loyalty and recognition, allowing it to maintain premium pricing on many of its products. Strategic partnerships with retailers and distributors enhance product availability and market penetration. The company also invests in innovation and product development to stay competitive, adapting to consumer trends and preferences, which further drives sales and revenue growth.
Reckitt Benckiser Group Earnings Call Summary
Earnings Call Date:Jul 24, 2025
(Q2-2025)
| % Change Since: |
Next Earnings Date:Mar 05, 2026
Earnings Call Sentiment Positive
The earnings call highlighted strong performance in Core Reckitt, with significant growth in emerging markets and successful cost-saving initiatives. However, challenges remain in the North American market and certain product lines, such as Essential Home and Mead Johnson Nutrition.Q2-2025 Updates
Positive Updates
Strong Core Reckitt Revenue Growth
Core Reckitt revenues grew 5.3% in Q2, and 4.2% for the half year, with excellent growth across emerging markets.
Improved Operating Profit and Margins
Adjusted operating profit increased 7%, with margin improvements of 110 basis points to 24.6%, driven by the Fuel for Growth program.
Emerging Markets Performance
Emerging Markets delivered 12.8% like-for-like growth for the half year, with double-digit revenue growth across all categories in Q2.
Successful Fuel for Growth Program
The Fuel for Growth program delivered a 190 basis point reduction in fixed costs in the first half.
Increase in Shareholder Returns
Interim dividend increased by 5%, and a new GBP 1 billion share buyback program was announced.
Negative Updates
North America Revenue Decline
Like-for-like net revenue in North America declined 1.7% in the half year, with particular softness in Q2.
Challenges in Essential Home and Mead Johnson Nutrition
Essential Home saw a like-for-like net revenue decline of 6.5% in the half, and Mead Johnson Nutrition declined 3.3%.
Self Care Revenue Decline
Self Care revenues declined 1.7% in the half, impacted by the shelf reset for Mucinex products.
Company Guidance
During Reckitt's Half Year 2025 results call, the company provided optimistic guidance for the remainder of the year. The company reported strong financial performance in the first half, with Core Reckitt revenues growing by 5.3% in Q2 and 4.2% for the half. Adjusted operating profit increased by 7%, leading to a 4.4% growth in first-half EPS. Looking ahead, Reckitt raised its full-year guidance for Core Reckitt like-for-like net revenue growth to over 4%, up from the previous 3% to 4%, driven by strong performance in Emerging Markets, which grew 14.9% in Q2. The company's Fuel for Growth program delivered cost savings ahead of plan, contributing to the 110 basis point increase in adjusted operating margin to 24.6%. Reckitt also announced a new GBP 1 billion share buyback program, emphasizing its commitment to returning excess cash to shareholders. Despite the positive outlook, the company remains cautious about the uncertain environment in North America and Europe, but it is confident in its ability to deliver sustained growth.Reckitt Benckiser Group Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
72
Positive
Cash Flow
80
Positive
| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Reckitt Benckiser Group Technical Analysis
Positive
15.72
Price Trends
15.57
Positive
15.31
Positive
14.21
Positive
Market Momentum
0.16
Negative
61.35
Neutral
64.04
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RBGLY, the sentiment is Positive. The current price of 15.72 is below the 20-day moving average (MA) of 15.73, above the 50-day MA of 15.57, and above the 200-day MA of 14.21, indicating a bullish trend. The MACD of 0.16 indicates Negative momentum. The RSI at 61.35 is Neutral, neither overbought nor oversold. The STOCH value of 64.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RBGLY.
Reckitt Benckiser Group Peers Comparison
UnderperformOutperform
Sector (―)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ― | ― | ― | ― | ― | ― | |
78 Outperform | $53.54B | 33.96 | 17.21% | 3.34% | 0.29% | -14.19% | |
73 Outperform | $139.75B | 23.34 | 28.36% | 3.75% | -0.30% | -14.60% | |
72 Outperform | $20.30B | 26.62 | 18.59% | 1.36% | 1.45% | 42.04% | |
69 Neutral | $339.32B | 21.20 | 31.90% | 2.83% | 1.23% | 17.97% | |
63 Neutral | $63.64B | 22.12 | 450.35% | 2.67% | -0.05% | 2.49% | |
63 Neutral | $34.03B | 17.37 | 136.87% | 4.90% | -10.04% | -23.41% |
* Sector Average
RBGLY
Reckitt Benckiser Group
16.08
4.31
36.62%
CHD
Church & Dwight
86.52
-18.02
-17.24%
CL
Colgate-Palmolive
79.73
-10.83
-11.96%
KMB
Kimberly Clark
102.94
-22.30
-17.81%
PG
Procter & Gamble
147.81
-16.92
-10.27%
UL
Unilever
65.57
5.67
9.47%
Reckitt Benckiser Group Corporate Events
Reckitt Benckiser Reports Strong Half-Year Results
Jul 25, 2025
Reckitt Benckiser Group Plc is a global consumer goods company specializing in health, hygiene, and nutrition products. It operates in the fast-moving consumer goods sector, known for its strong brand portfolio including Dettol, Lysol, and Durex.
Reckitt Benckiser’s Earnings Call Highlights Growth and Challenges
Jul 25, 2025
Reckitt Benckiser Group Plc-ADR’s latest earnings call revealed a generally positive sentiment, marked by strong performance in Core Reckitt and Emerging Markets. The company has successfully gained market share and enhanced operational efficiency. However, challenges persist in the North American market and the Self Care category. Despite these hurdles, Reckitt’s strategic initiatives and financial metrics indicate a positive trajectory for the company.
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.